APDN — Applied DNA Sciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapValue Trap

Annual balance sheet for Applied DNA Sciences, fiscal year end - September 30th, USD millions except per share, conversion factor applied.

	2020 September 30th	2021 September 30th	2022 September 30th	2023 September 30th	2024 September 30th
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	7.79	6.55	15.2	7.15	6.43
Net Total Accounts Receivable
Net Total Receivables	0.194	2.8	3.07	0.256	0.362
Total Inventory
Prepaid Expenses
Total Current Assets	9.08	11.3	19.9	8.13	8.05
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1.28	3.02	2.22	2.08	1.29
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	11.3	14.4	22.3	13.7	12.8
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	4.27	3.27	4.19	2.85	2.4
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	5.62	3.3	9.35	8.7	3.65
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	5.72	11.1	12.9	4.95	9.14
Total Liabilities & Shareholders' Equity	11.3	14.4	22.3	13.7	12.8
Total Common Shares Outstanding
Total Preferred Shares Outstanding